全文获取类型
收费全文 | 3077篇 |
免费 | 10篇 |
专业分类
电工技术 | 10篇 |
化学工业 | 70篇 |
金属工艺 | 18篇 |
机械仪表 | 13篇 |
建筑科学 | 53篇 |
能源动力 | 10篇 |
轻工业 | 37篇 |
水利工程 | 3篇 |
石油天然气 | 2篇 |
无线电 | 41篇 |
一般工业技术 | 128篇 |
冶金工业 | 2621篇 |
原子能技术 | 5篇 |
自动化技术 | 76篇 |
出版年
2021年 | 7篇 |
2020年 | 4篇 |
2019年 | 4篇 |
2018年 | 7篇 |
2017年 | 7篇 |
2016年 | 11篇 |
2015年 | 7篇 |
2014年 | 11篇 |
2013年 | 30篇 |
2012年 | 15篇 |
2011年 | 18篇 |
2010年 | 12篇 |
2009年 | 19篇 |
2008年 | 27篇 |
2007年 | 22篇 |
2006年 | 26篇 |
2005年 | 15篇 |
2004年 | 32篇 |
2003年 | 21篇 |
2002年 | 15篇 |
2001年 | 15篇 |
2000年 | 20篇 |
1999年 | 102篇 |
1998年 | 773篇 |
1997年 | 450篇 |
1996年 | 281篇 |
1995年 | 159篇 |
1994年 | 162篇 |
1993年 | 164篇 |
1992年 | 35篇 |
1991年 | 41篇 |
1990年 | 51篇 |
1989年 | 70篇 |
1988年 | 52篇 |
1987年 | 42篇 |
1986年 | 30篇 |
1985年 | 28篇 |
1983年 | 5篇 |
1982年 | 17篇 |
1981年 | 14篇 |
1980年 | 24篇 |
1979年 | 11篇 |
1978年 | 11篇 |
1977年 | 61篇 |
1976年 | 124篇 |
1975年 | 6篇 |
1974年 | 3篇 |
1973年 | 6篇 |
1971年 | 3篇 |
1955年 | 2篇 |
排序方式: 共有3087条查询结果,搜索用时 15 毫秒
21.
A. Lowe 《Journal of Materials Science》1996,31(4):1005-1011
The transverse compressive behaviour of a structurally complex carbon-epoxy unidirectional composite (T300/914) has been investigated over various temperatures and test rates. The mechanical behaviour was found to mirror the transverse tensile behaviour of the material, with the viscoelastic response being different between micro- and macroproperties. Composite macrofracture was found to occur at ±34 ° to the loading axis and was regular, whereas fracture of the bulk resin was irregular and occurred by Poisson forces, rather than compressive forces. The performance of the test fixture was assessed and found to be adequate for composites testing. An optimum specimen gauge length was determined as the ASTM recommendation was found to be unsatisfactory. 相似文献
22.
Y Xu DC Gaudette JD Boynton A Frankel XJ Fang A Sharma J Hurteau G Casey A Goodbody A Mellors 《Canadian Metallurgical Quarterly》1995,1(10):1223-1232
Ascites from ovarian cancer patients contain potent growth-promoting activity toward human ovarian cancer cells both in vitro and in vivo. This activity is associated with rapid increases in cytosolic free calcium ([Ca2+]i) as a consequence of phosphoinositide hydrolysis. In this study, we describe the purification, characterization, and identification of an ovarian cancer activating factor (OCAF) from ascites of ovarian cancer patients. We have isolated OCAF by a combination of solvent extraction, silica gel chromatography, and TLC. Mass spectral analysis, phospholipase sensitivity, and gas chromatographic behavior of purified OCAF indicate that OCAF is composed of various species of lysophosphatidic acid (LPA), including LPAs with polyunsaturated fatty acyl chains (linoleic, arachidonic, and docosahexaenoic acids). However, OCAF is more potent than sn-1 palmitoyl, oleoyl, or stearoyl LPA in increasing [Ca2+]i in ovarian cancer cells. The ability of OCAF to alter [Ca2+]i is sensitive to the effects of lipoxidase, whereas the activity of sn-1 oleoyl, stearoyl, or palmitoyl LPA is not, suggesting that polyunsaturated bonds in the fatty acyl chain of OCAF may account for its increased ability to activate ovarian cancer cells. Furthermore, a sn-2 linoleoyl LPA generated by phospholipase A1 treatment of synthetic phosphatidic acid is much more active than are sn-1 palmitoyl, stearoyl, or oleoyl LPA in increasing [Ca2+]i in ovarian cancer cells. Taken together, these data suggest that the ability of OCAF to increase cellular calcium may reside in the structure and/or location of the fatty acyl chain of LPA. Purified OCAF, at concentrations similar to those present in ascites from ovarian cancer patients, was sufficient to induce proliferation of ovarian cancer cells, as indicated by thymidine incorporation, reduction of 3-(4,5-dimethylthiazol-2-yl)-2, 5-diphenyltetrazolium bromide, or colony formation. However, even at optimal concentrations of OCAF, proliferation was lower than that induced by FCS or ascites from ovarian cancer patients, indicating that, although OCAF may be a major regulator of ovarian cancer cells in vivo, it is not the sole mediator present in ascites, and it likely functions in concert with other growth factor activities. 相似文献
23.
24.
DC Sutton R Kluger SU Ahmed SC Reimold JB Mark 《Canadian Metallurgical Quarterly》1994,108(3):576-582
This study assessed the value of biplane transesophageal echocardiographic assessment of diastolic flow reversal in the descending aorta as an alternative to Doppler color flow imaging in determining severity of aortic regurgitation. In 45 patients undergoing cardiac operations, the severity of aortic regurgitation was assessed by semiquantitative grading of the width of the Doppler color flow regurgitant jet relative to the left ventricular outflow tract, and the presence of diastolic flow reversal was assessed with pulsed-wave Doppler measurements at three sites in the descending aorta. In four patients, the diastolic flow reversal method was the only available form of assessment because of inadequate visualization of the left ventricular outflow tract beneath a mitral valve prosthesis. Diastolic flow reversal in the descending aorta was not observed in patients without aortic regurgitation and was always present in patients with severe aortic regurgitation. Aortic valve replacement successfully eliminated descending aortic flow reversal in all 19 patients in whom it was present before valve replacement. Identification of diastolic flow reversal at multiple sites in the descending aorta with biplane transesophageal echocardiography helps to confirm the presence of severe aortic regurgitation and can serve as an alternative method of assessment when visualization of the left ventricular outflow tract is impaired. 相似文献
25.
26.
27.
KE Ensrud DM Black L Palermo DC Bauer E Barrett-Connor SA Quandt DE Thompson DB Karpf 《Canadian Metallurgical Quarterly》1997,157(22):2617-2624
BACKGROUND: The efficacy of antiresorptive therapy in preventing fractures in women at highest fracture risk, such as very elderly women or those with severe osteoporosis, is uncertain. PARTICIPANTS AND METHODS: Using data from a double-blind, randomized, placebo-controlled clinical trial that enrolled 2027 postmenopausal women aged 55 to 81 years with low femoral neck bone mineral density (BMD) and existing vertebral fractures, we examined the consistency of the effect of treatment with alendronate sodium in preventing fractures within a priori-specified risk subgroups defined at baseline by age, bone density, number of preexisting vertebral fractures, and history of postmenopausal fracture. The women were randomized to oral administration of alendronate or placebo and followed up for an average of 2.9 years. The initial dose of alendronate sodium was 5 mg/d; the dosage was increased from 5 to 10 mg/d at 24 months. New vertebral fractures, the primary end point of this arm of the trial, were defined by morphometry as a decrease of 20% and at least 4 mm in any vertebral height between baseline and a follow-up radiograph at 36 months. Incident clinical fractures, the secondary end point, included nonspine and clinical (symptomatic) vertebral fractures. All clinical fractures were confirmed with x-ray film reports or, in the case of clinical vertebral fractures, x-ray films. RESULTS: Overall, there was a 47% significant reduction in risk of new vertebral fractures in the alendronate group compared with the placebo group. The reduction in risk of new vertebral fracture was consistent across fracture risk categories including age (relative risk [RR], 0.49 in women < 75 years compared with 0.62 in those > or = 75 years), BMD (RR, 0.54 in women with a femoral neck BMD < 0.59 g/cm2 [median] compared with 0.53 in those with a BMD > or = 0.59 g/cm2), and number of preexisting vertebral fractures (RR, 0.58 in women with 1 vertebral fracture compared with 0.52 in those with > or = 2). The overall significant 28% reduction in risk of incident clinical fractures in the alendronate group compared with the placebo group was also observed within these subgroups. Compared with the number of lower-risk women, a similar or smaller number of high-risk women needed to be treated to prevent 1 fracture. For example, 8 women aged 75 years or older compared with 9 women younger than 75 years, or 4 women with 2 or more existing vertebral fractures compared with 16 women with 1 existing vertebral fracture, needed to be treated with alendronate for 5 years to prevent 1 new vertebral fracture. CONCLUSIONS: Alendronate effectively reduces fracture risk in postmenopausal women with vertebral fractures and low BMD, including those women at highest risk because of advanced age or severe osteoporosis. Since the risk reductions observed with alendronate treatment were consistent within fracture risk categories, more fractures were prevented by treating women at highest risk. 相似文献
28.
Fitting parameterized three-dimensional models to images 总被引:11,自引:0,他引:11
Model-based recognition and motion tracking depend upon the ability to solve for projection and model parameters that will best fit a 3-D model to matching 2-D image features. The author extends current methods of parameter solving to handle objects with arbitrary curved surfaces and with any number of internal parameters representing articulation, variable dimensions, or surface deformations. Numerical stabilization methods are developed that take account of inherent inaccuracies in the image measurements and allow useful solutions to be determined even when there are fewer matches than unknown parameters. The Levenberg-Marquardt method is used to always ensure convergence of the solution. These techniques allow model-based vision to be used for a much wider class of problems than was possible with previous methods. Their application is demonstrated for tracking the motion of curved, parameterized objects 相似文献
29.
30.
A new technique for right heart catheterization using a Mullins' sheath is described. This device allows a Swan-Ganz catheter to reach pulmonary artery position easily and permits simultaneous pressure recordings in right heart chambers, thus avoiding a double venous puncture and two catheters. This new technique, its indications, and our experience in 29 patients are described. It is most useful in patients with severe pulmonary hypertension and in those conditions in which accurate right heart pressure measurements are needed. 相似文献